A61K 39/085
Staphylococcus
A61K39/085 (Staphylococcus) appears on 385 US grants and 594 published applications in this corpus.
Search patents in A61K- Granted patents
- 385
- Published applications
- 594
- Assignees
- 240
- Inventors
- 876
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 9 |
| 2003 | 5 | 7 |
| 2004 | 4 | 15 |
| 2005 | 2 | 7 |
| 2006 | 8 | 17 |
| 2007 | 6 | 15 |
| 2008 | 5 | 24 |
| 2009 | 4 | 13 |
| 2010 | 8 | 20 |
| 2011 | 10 | 24 |
| 2012 | 11 | 30 |
| 2013 | 14 | 27 |
| 2014 | 32 | 39 |
| 2015 | 25 | 45 |
| 2016 | 27 | 40 |
| 2017 | 26 | 40 |
| 2018 | 21 | 29 |
| 2019 | 23 | 26 |
| 2020 | 21 | 36 |
| 2021 | 23 | 28 |
| 2022 | 19 | 28 |
| 2023 | 17 | 19 |
| 2024 | 14 | 26 |
| 2025 | 10 | 19 |
| 2026 | 6 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Staphylococcus aureus vaccine compositions15 Sep 2026US 12,734,227 B2New York University
- Vaccine composition comprising recombinant protein of Staphylococcus aureus attenuated enterotoxin and cytotoxin30 Jun 2026US 12,667,610 B2Mississippi State University
- Methods and compositions for treating inflammatory skin disease with recombinant microorganisms10 Mar 2026US 12,569,521 B2Azitra Inc
- Ostrich antibody for bacterial infectious diseases3 Mar 2026US 12,564,624 B2Ostrich Pharma KK
- Oral vaccine via dental bacteria and emitted peptides to prevent COVID-19 infection3 Feb 2026US 12,539,328 B2
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Methods and compositions comprising staphylococcus protein a (spa) variants24 Sep 2026US 2026/0284169 A1The University of Chicago
- Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers27 Aug 2026US 2026/0250332 A1Leidos, Inc.
- Immune checkpoint blockade therapy for treating staphylococcus aureus infections30 Jul 2026US 2026/0217828 A1University of Rochester
- Engineered bacteria for cellular barrier maintenance and protection30 Jul 2026US 2026/0218210 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Method of potentiating an immune response425US 5,075,109 ASouthern Research Institute · 1991
- Submicron emulsions as vaccine adjuvants129US 5,961,970 APharmos Corporation · 1999
- Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants92US 5,585,098 AOvimmune, Inc. · 1996
- Broadly reactive opsonic antibodies that react with common staphylococcal antigens81US 5,571,511 AU.S. Government · 1996
- Antigen library immunization76US 6,541,011 B2Maxygen, Inc. · 2003